Egyéb fitokannabionoidok és élettani hatásuk
Besides CBD the broad and full spectrum products contain otherphytocannabinoids as well. These are present in a very small amount but might have different physiological effects due to the difference in their structure and they might amplify the effect of other substances what we call „cross effect”. CeBDon products contain the following phytocannabinoids as well: CBN (Cannabinol), CBG (Cannabigerol), CBC (Cannabichromene) and the full spectrum products contain THC (Δ9-tetrahydrocannabinol) too.
CBG: The Cannabigerol (CBG) is the decarboxylated form of cannabigerolic acid (CBGa) which gets created under the influence of heat. It is a precursor cannabinoid which means that in the presence of various enzymes CBGa can turn to the acid of a different type of phytocannabinoid (CBDa, THCa, CBCa). As a result, it is hard to extract the CBG as only 1% of it remains in the plant during the processing, however, researches performed in the past 10-15 years suggest several beneficial properties. Promising results have been achieved in animal model researches related to Huntigton’s
CBN: The cannabinol (CBN) is formed in the presence of oxygen as a metabolite of THC but contrary to the THC it’s not psychotropic. Similarly, as other cannabinoids it activates the CB1 and CB2 receptors. Studies from previous years report potential antibacterial and anti-inflammatory effects and suggest therapeutic benefit in amyotrophic lateral sclerosis disease (Lou Gehrig syndrome) and in Glaucoma too.
CBC: The cannabichromene (CBC) might have very low effect on the CB receptors of the endocannabinoid system but it can develop a strong connection to the TRPA1 and TRPV receptors which play an important role in cell level activities like processing temperature and other perception related actions. In terms of studies we have less literature available but in certain cases potential antibacterial, analgetic, anti-inflammatory and antidepressant-like effects have been recorded.
CBC, CBG, CBN are not psychotropic, are not under any restriction and are not listed as illegal drugs. The list phytocannabinoid on the list is the THC which has no observable psychotropic effect in low concentration (below 0.2%) but might have positive physiological effect by itself and may increase the efficiency of other substances.
THC: THC (Δ9-tetrahydrocannabinol) is a psychotropic phytocannabinoid and that’s the reason why it is listed as „Schedule 1” drug in most of the countries. THC is allowed in CBD oils as long as its concentration is not more than 0.2/0.3%. (In Hungary the max. concentration of THC allowed is 0.04% which the CeBDon full spectrum oils comply with.) Even in low concentration the THC might promote the biological and physiological effect of other phytocannabinoids.
Besides the mentioned attributes, it is important to emphasize the mechanism through which phytocannabinoids promote each other’s effect (entourage effect) which also supports the potentially higher efficiency of broad and full spectrum products compared to the isolates. Information provided here can be found in scientific literature and have been referenced as URLs in the appropriate part of the text. It’s important to emphasize that no product containing CBD or other phytocannabinoids can replace balanced and healthy diet or the medication therapy of any disease. In case you suffer from any of the before mentioned diseases and you would like to include CeBDon CBD oil in your treatment it is by all means important to consult with your treating physician first.